Esperion Therapeutics | ESPR - 市值

金融业

USD

USD 462.53M

现金及等价物

USD 156.16M

USD 27.85M

USD 459.46M

USD 300.36M

USD 262.92M

股息收益率

0

USD 85.23M

USD -9.93M

240

EPS每股收益

USD 0.26

股本和储备

USD -307.93M

USD 140.59M

债务利息支出

USD 22.64M

USD -0.15

USD 457.65M

USD 584.8M

USD 61.83M

USD 83.21M

USD 85.23M

普通股股本

USD 245.22M

129.79

USD 63.67M

USD 168.45M

销售和管理费用

USD 39.43M

USD 104.21M

贸易债权人

USD 68.41M

应收帐款人

USD 140.19M

	市值	更改		日
AbbVie	USD 384.69B		19.14B	2026-03
Alnylam Pharmaceuticals	USD 44.15B		8.39B	2026-03
Alterity Therapeutics Limited	AUD 47M		9M	2026-07
Amarin	USD 290M		51M	2025-12
Amgen	USD 189.89B		13.64B	2026-03
Biogen	USD 26.9B		1.09B	2026-03
BioMarin Pharmaceutical	USD 10.86B		553M	2026-03
Cipla	INR 988.89B		231.9B	2026-03
CSL	USD 55.89B		20.42B	2025-12
Cytokinetics	USD 8.19B		420M	2026-03
Eli Lilly	USD 869.02B		146.97B	2026-03
Esperion Therapeutics	USD 885M		351M	2025-12
Geron	USD 955M		112M	2026-03
Halozyme Therapeutics	USD 7.66B		257M	2026-03
Heron Therapeutics	USD 238M		7M	2025-12
Ionis Pharmaceuticals	USD 12.46B		356M	2026-03
Merck	USD 297.1B		35.84B	2026-03
Moderna	USD 20.15B		8.53B	2026-03
Nektar Therapeutics	USD 12.82B		11.96B	2026-07
Pfizer	USD 153.81B		12.24B	2026-03
PTC Therapeutics	USD 5.64B		460M	2026-03
Regeneron Pharmaceuticals	USD 81.68B		560M	2026-03
Sanofi	EUR 100.27B		605.48M	2026-03
Sarepta Therapeutics	USD 2.28B		30M	2026-03
United Therapeutics	USD 25.19B		4.21B	2026-03
Vanda Pharmaceuticals	USD 279M		6M	2024-12